Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
Anti-Cancer Drugs
|
September 23, 2000
FR901228 causes mitotic arrest but does not alter microtubule polymerization
V Sandor, A R Robbins, R Robey, et al.
Cancer Genetics and Cytogenetics
|
December 1, 1996
Chromosomal changes and progressive tumorigenesis of human bronchial epithelial cell lines
Y Ohnuki, R R Reddel, S E Bates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1997
Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi
C C Chen, B Meadows, J Regis, et al.
The Journal of Clinical Investigation
|
August 1, 1995
Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells
S Scala, A Budillon, Z Zhan, et al.
The Journal of Pediatrics
|
September 1, 1982
Effect of intensive insulin treatment on linear growth in the young diabetic patient
M C Rudolf, R S Sherwin, R Markowitz, et al.
Journal of the National Cancer Institute
|
October 23, 1997
Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns
K Wosikowski, D Schuurhuis, K Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 14, 1998
Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells
M V Blagosklonny, P Giannakakou, M Wojtowicz, et al.
Journal of Cellular Biochemistry
|
June 15, 1997
Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression
J S Lee, S Scala, Y Matsumoto, et al.
Journal of Cellular Physiology
|
October 1, 1993
Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line
B Dickstein, E M Valverius, K Wosikowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel
M H Kang, W D Figg, Y Ando, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
Anti-Cancer Drugs
|
September 23, 2000
FR901228 causes mitotic arrest but does not alter microtubule polymerization
V Sandor, A R Robbins, R Robey, et al.
Cancer Genetics and Cytogenetics
|
December 1, 1996
Chromosomal changes and progressive tumorigenesis of human bronchial epithelial cell lines
Y Ohnuki, R R Reddel, S E Bates, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1997
Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi
C C Chen, B Meadows, J Regis, et al.
The Journal of Clinical Investigation
|
August 1, 1995
Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells
S Scala, A Budillon, Z Zhan, et al.
The Journal of Pediatrics
|
September 1, 1982
Effect of intensive insulin treatment on linear growth in the young diabetic patient
M C Rudolf, R S Sherwin, R Markowitz, et al.
Journal of the National Cancer Institute
|
October 23, 1997
Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns
K Wosikowski, D Schuurhuis, K Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 14, 1998
Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells
M V Blagosklonny, P Giannakakou, M Wojtowicz, et al.
Journal of Cellular Biochemistry
|
June 15, 1997
Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression
J S Lee, S Scala, Y Matsumoto, et al.
Journal of Cellular Physiology
|
October 1, 1993
Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line
B Dickstein, E M Valverius, K Wosikowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel
M H Kang, W D Figg, Y Ando, et al.
Page
of 11